首页 › 重度抑郁症 › 阿肯色州 › Little Rock
Little Rock AR 重度抑郁症临床试验
14项针对 重度抑郁症的研究正在 Little Rock及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
招募中3 期
- Preferred Research Partners, Inc., Little Rock
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
招募中3 期
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 距离 15 英里
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
招募中3 期
- SanRo Clinical Research Group LLC WCG Clinical Network, Bryant · 距离 15 英里
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
招募中3 期
- Vanda Investigational Site, Little Rock
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
招募中4 期
- Neurocrine Clinical Site, Bryant · 距离 15 英里
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
招募中3 期
- SanRo Clinical Research Group, Bryant · 距离 15 英里
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
招募中2 期
- Draig Clinical Site, Little Rock
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
招募中2 期
- Draig Clinical Site, Little Rock
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Bryant · 距离 15 英里
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
招募中3 期
- Woodland International Research Group, Little Rock
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Little Rock
- Neurocrine Clinical Site, Bryant · 距离 15 英里
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
招募中2 期
- Preferred Research Partners /ID# 279206, Little Rock
- Woodland International Research Group /ID# 277605, Little Rock
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)
招募中2 期
- Pillar Clinical Research, LLC, Little Rock
- Preferred Research Partners, Inc., Little Rock
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
招募中3 期
- Neurocrine Clinical Site, Little Rock
其他城市的 重度抑郁症试验
- New York City, NY36 项研究
- Boston, MA31 项研究
- Atlanta, GA25 项研究
- Philadelphia, PA23 项研究
- Orlando, FL19 项研究
- Miami, FL18 项研究
- Chicago, IL17 项研究
- Tampa, FL17 项研究
- Houston, TX16 项研究
- San Diego, CA16 项研究
- Austin, TX13 项研究
- Las Vegas, NV13 项研究
Little Rock的其他研究
- 精神分裂症19 项研究
- 癌症（所有类型）14 项研究
- 急性髓系白血病13 项研究
- 非小细胞肺癌13 项研究
- 肥胖症11 项研究
- 子宫内膜癌10 项研究
- 抑郁症10 项研究
- 2型糖尿病10 项研究
- 肺癌9 项研究
- 心血管疾病9 项研究
- 膀胱癌9 项研究
- 心力衰竭9 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。